Cancer Detection And Diagnosis Research obligations in FY2025

The relationship: Cancer Detection And Diagnosis Research and fiscal year 2025

Two tables meet. One table is CFDA 93.394 (Cancer Detection And Diagnosis Research). The other is fiscal year 2025. $530,433,998.82 is the obligation aggregate for rows that carry both keys on the yearlyTrend table. The FY2025 cell is 13.1% of the program-wide $4,051,456,547.91 book on 1,875 awards. The remaining catalog dollars sit on other fiscal-year rows this page does not reprint. This page is that program–year join, not a patient census, a screening ranking, a named-lab roster, or a trial-enrollment table. The join does not prove that fiscal year 2025 caused Cancer Detection And Diagnosis Research activity, only that USAspending coded the two keys together. FEC donation tables do not fund these USAspending obligations.

SpendingVault indexes the cell from USAspending.gov. The catalog title on the program side is CANCER DETECTION AND DIAGNOSIS RESEARCH. The year on the other side is federal fiscal year 2025. Neither label is a contractor, a place of performance, or an awarding-agency code — this packet publishes no awarding agency and no named recipients. Parent without the year: /programs/93.394/ (CFDA 93.394). Parent without the CFDA: /fiscal-years/2025/ (FY2025 federal spending). 390 FY2025 awards make this a research-award file, still not a count of laboratories or investigators. Outlays are not this field.

Program facts that stay on CFDA 93.394

CFDA 93.394 is the Catalog of Federal Domestic Assistance identifier for Cancer Detection And Diagnosis Research. The official title is CANCER DETECTION AND DIAGNOSIS RESEARCH. The program-wide obligation total in this extract is $4,051,456,547.91 across 1,875 awards. That figure is a program rollup, not a second headline for the FY2025 cell unless the two amounts match. Do not treat $4,051,456,547.91 as cash Treasury already sent. SpendingVault does not grade program performance. Do not mix arthritis research (93.846) or allergy research (93.855) into this 93.394 cell. Mixing those other keys into $530,433,998.82 would invent a combined total the packet never computed.

Open CFDA 93.394 at /programs/93.394/ for the program hub. That page is not this join: it can include other fiscal years if the extract lists them, and it is still obligations rather than outlays. This ties page stays on CFDA 93.394 in FY2025 only. Campaign-finance filings do not fund these USAspending obligations. Unique recipients remain unpublished. Later bulk files can move both the dollars and the 390-award count without changing the join keys.

The year key on Cancer Detection And Diagnosis Research

Federal fiscal year 2025 is the time key on this yearlyTrend row. The year hub FY2025 federal spending at /fiscal-years/2025/ rolls up every program that year in the index, not only Cancer Detection And Diagnosis Research. Reading $530,433,998.82 as all FY2025 federal obligations would over-read this cell. The join is one CFDA inside one fiscal year, not a Budget Appendix score and not a Treasury cash statement. Agency splits, place-of-performance maps, and recipient UEIs are omitted from this packet.

A later USAspending ingest can restate $530,433,998.82 without changing CFDA 93.394 or fiscal year 2025. Keep both join sides on the same line as the dollar figure. The All programs index at /programs/ still lists other catalog lines. The All spending ties index at /ties/ still lists other pairs. Neither parent equals this cell.

Why 390 is not a count of laboratories or investigators

The extract lists 390 awards on the Cancer Detection And Diagnosis Research × FY2025 table. That is an award-record count for this yearlyTrend cell, not a count of laboratories or investigators. Unique recipients are unpublished. Continuations and modifications can add lines without naming a new organization. Dividing $530,433,998.82 by 390 is not published here as a typical award size, because the packet does not say the rows are comparable. The program-wide award count is 1,875, a different denominator.

What the Cancer Detection And Diagnosis Research FY2025 table omits

An obligation is a legal commitment. An outlay is a payment. $530,433,998.82 is the former. Citing it as cash already cleared on Cancer Detection And Diagnosis Research in FY2025 over-reads the field. Keep $530,433,998.82 labeled as Cancer Detection And Diagnosis Research obligations in fiscal year 2025. No named contractors or labs or investigators appear here. Quote Cancer Detection And Diagnosis Research and FY2025 with $530,433,998.82. Keep CFDA 93.394 in the citation.

Budget justifications and press releases are not the source of this cell. If a chart mixes a different CFDA with FY2025 or a different fiscal year with Cancer Detection And Diagnosis Research, the chart has left this join. Do not mix arthritis research (93.846) or allergy research (93.855) into this 93.394 cell. Correlation with news headlines is not causation.

Hubs for CFDA 93.394 × FY2025

Open /programs/93.394/ for CFDA 93.394, /fiscal-years/2025/ for FY2025 federal spending, /programs/ for All programs, and /ties/ for All spending ties. Those parents are larger than this cell. Keep both join sides on the same line as $530,433,998.82. USAspending.gov remains the source. A ties page exists because two tables meet. One table is CFDA 93.394. The other is fiscal year 2025. $530,433,998.82 is the obligation sum on that intersection, not a forecast and not a claim that Cancer Detection And Diagnosis Research caused any outcome statistic to move.

Step off this pair through the internal links. Keep Cancer Detection And Diagnosis Research and FY2025 together when citing $530,433,998.82. CFDA 93.394's program-wide award-record count is 1,875, not a FY2025-only census of labs or investigators. Obligations of $530,433,998.82 are not outlays. Original filings remain on USAspending.gov for this 93.394 × FY2025 pair. Campaign-finance tables do not fund these USAspending obligations. Unique recipients remain unpublished. Quote CFDA 93.394, fiscal year 2025, and $530,433,998.82 in one sentence.

Questions

What is the Cancer Detection And Diagnosis Research obligation total for fiscal year 2025?

USAspending.gov records $530,433,998.82 in CFDA 93.394 obligations tagged to fiscal year 2025 across 390 awards. That cell is 13.1% of the program-wide $4,051,456,547.91 book, not an outlay. The pair is Cancer Detection And Diagnosis Research plus FY2025.

Are 390 FY2025 awards the same as 1,875 program-wide awards?

No. 390 is an FY2025 award-record count on a research-award file. The program-wide extract lists 1,875 awards. Recipients are unpublished. The count is not a count of laboratories or investigators. USAspending.gov remains the source for this pair. Unique recipients remain unpublished on this 93.394 × FY2025 join.

Does $530,433,998.82 equal Cancer Detection And Diagnosis Research outlays already paid?

No. $530,433,998.82 is an obligation aggregate. Outlays are unpublished. Payments from the Treasury can lag or differ. FEC donations do not fund this USAspending cell. Original filings remain on USAspending.gov. The program-wide book is $4,051,456,547.91 on 1,875 awards, a different rollup.

Where are the CFDA 93.394 and FY2025 hubs?

/programs/93.394/ is the program parent. /fiscal-years/2025/ is the FY2025 parent. /programs/ lists programs. /ties/ lists other pairs. Prefer those tables after later ingests; this page quotes Cancer Detection And Diagnosis Research × FY2025 at $530,433,998.82. Keep CFDA 93.394 in the citation alongside fiscal year 2025.